ISIS : Analysis & Opinions

  1. How To Profit From These 3 Overvalued Sectors

    January 22, 2015
    Flea markets crack me up. Most of the vendors seem like they cleaned the junk from their garage and assigned an arbitrary, ...
  2. How the S&P 500 and Russell 2000 Indexes Differ

    January 22, 2015
    The S&P 500 and Russell 2000 are used as benchmarks for broader segments of the U.S. stock market. Each index has its own ...
  3. Isis Pharmaceuticals Earns Milestone Payment from Biogen - Analyst ...

    January 15, 2015
    Isis Pharmaceuticals (ISIS) earned a milestone payment of $7 million from partner Biogen for the advancement of the ongoing ...
  4. Isis Pharmaceuticals Improves 2014 Outlook, Shares Up - Analyst ...

    January 9, 2015
    Isis Pharmaceuticals (ISIS) gained around 4.9% after the company updates its 2014 outlook.
  5. Biotech Stock Roundup: Kite Flies High on Amgen Deal, Isis Soars ...

    January 7, 2015
    Collaborations and agreements continued to make headlines in the biotech sector with companies like Gilead (GILD), Amgen ...
  6. 2 Pharmaceutical Stocks Ready to Beat Earnings This Quarter - ...

    January 6, 2015
    These two pharma stocks could be great picks this earnings season.
  7. Isis Pharmaceuticals Up on Collaboration with J&J - Analyst ...

    January 6, 2015
    Isis Pharmaceuticals (ISIS) inked a global collaboration with Johnson & Johnson's (JNJ) Janssen Biotech, Inc for the ...
  8. Big Mover Stocks With More Big Move Potential

    May 26, 2014
    These stocks had big price moves recently, and cosidering where the price is from a technical perspective, further big moves ...
  9. Alnylam Basking In Orphan Drug Attention

    May 28, 2013
    Alnylam has already seen a big run, but clinical success could bring even more gains.
  10. Isis Pharma Updates on its Pipeline - Analyst Blog

    January 11, 2013
    Isis Pharmaceuticals, Inc. (ISIS) recently provided an update on its pipeline. Isis Pharma boasts of a robust pipeline. The ...
  11. Healthcare Stocks, Including Pharmacyclics, Making Big Moves ...

    December 17, 2012
    On a good day for the market, the Nasdaq has risen 0.5%, the S&P 500 has increased 0.6% and the Dow has moved up 0.5%. ...
  12. Alnylam-ISIS Venture Prices IPO - Analyst Blog

    October 5, 2012
    Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently announced ...
  13. Expedia and More Big Movers on the Nasdaq on September 21, 2 ...

    September 21, 2012
    This morning, the Nasdaq has moved little, the S&P 500 has decreased 0.3% and the Dow has been relatively flat. The recent ...
  14. Healthcare Sector's Biggest Movers: HCA Holdings and More

    August 6, 2012
    The market is currently up, with the Nasdaq climbing 1%, the S&P 500 rising 0.5% and the Dow up 0.6%. The healthcare ...
  15. Isis Pharma Stays Neutral - Analyst Blog

    July 11, 2012
    We recently reiterated our Neutral recommendation on Isis Pharmaceuticals (ISIS), which carries a Zacks #3 Rank (short-term ...
  16. XOMA Rearranges The Deck Chairs One More Time

    September 2, 2011
    XOMA changes management again, but should anybody care?
  17. A Deal At Last For Sanofi And Genzyme

    February 18, 2011
    Though Sanofi finally got its way in acquiring Genzyme, time will determine if stockholders will truly benefit.
  18. There Is Life After Death, At Least In Biotech

    June 22, 2010
    Clinical failure is not the end of the story for all biotechs. How do some survive while others disappear?
Trading Center